Director/PDMR Shareholding

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

Smith & Nephew plc SPON ADR American Depositary Shares (ADS)

Identification code

ISIN: US83175M2052

Nature of the transaction

Director and PDMRs are participants of the Company's Employee Stock Purchase Plan, which purchased American Depository Shares through the Company's Dividend Re-Investment Plan following the 2024 final dividend payment on 28 May 2025.

Date of Transaction

2025-06-04

Place of Transaction

New York Stock Exchange

Name

Director / PDMR

Price ($)

Volume

Aggregated information

Craig Gaffin

(President, Global Orthopaedics)

PDMR

29.3442

33.73275

N/A Single Transaction

Mizanu Kebede

(Chief Quality & Regulatory Affairs Officer)

PDMR

29.3442

19.37144

N/A Single Transaction

Deepak Nath

(Chief Executive Officer)

Director

29.3442

35.79737

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

29.3442

35.64110

N/A Single Transaction

Scott Schaffner

(President, Sports Medicine)

PDMR

29.3442

46.62612

N/A Single Transaction